|
|
甲基强的松龙对小儿神经免疫性疾病的临床疗效及不良反应的影响
|
Abstract:
目的：探究甲基强的松龙对小儿神经免疫性疾病的临床疗效，以及不良反应的影响。方法：选取我院2018年3月~2019年12月收治的小儿神经免疫性疾病患儿72例，根据随机数字表法将其分为两组，各36例，对照组采用常规治疗，观察组采用甲基强的松龙治疗，对比两组患儿的治疗效果和不良反应情况。结果：对照组治疗总有效率低于观察组(P < 0.05)；对照组不良反应发生率高于观察组(P < 0.05)。结论：甲基强的松龙治疗小儿神经免疫性疾病的效果良好，不良反应相对较少，安全性高，值得应用。
Objective: To explore the effect of methylprednisolone on the clinical efficacy and adverse reactions of children with neuroimmune diseases. Methods: 72 children with neuroimmune diseases treated in our hospital from March 2018 to December 2019 were randomly divided into two groups with 36 cases in each group. The control group was treated with routine treatment and the observation group was treated with methylprednisolone. The therapeutic effects and adverse reactions of the two groups were compared. Results: The total effective rate of the control group was lower than that of the observation group (P < 0.05); the incidence of adverse reactions in the control group was higher than that in the observation group (P < 0.05). Conclusion: Methylprednisolone is effective in the treatment of neuroimmune diseases in children, with relatively few adverse reactions and high safety, which is worthy of application.
| [1] | 叶明怡. 甲基氢化泼尼松在小儿神经免疫性疾病临床治疗中的应用价值[J]. 吉林医学, 2014(20): 4444-4444. |
| [2] | 邹艳萍. 甲基强的松龙治疗小儿神经免疫性疾病28例临床分析[J]. 中国实用神经疾病杂志, 2013, 16(2): 70-71. |
| [3] | Lindner, A., Schalke, B. and Toyka, K.V. (1997) Outcome in Juvenile-Onset Myasthenia Gravis: A Retrospective Study with Long-Term Follow-Up of 79 Patients. Journal of Neurology, 244, 515-520.
https://doi.org/10.1007/s004150050135 |
| [4] | 解福平, 贾风来, 曾月忠. 大剂量甲基强的松龙冲击治疗脱髓鞘疾病16例[J]. 中华实用儿科临床杂志, 1998(1): 32-32. |
| [5] | 钟小理, 谢荣迪. 大剂量甲基强的松龙治疗急性播散性脑脊髓炎的疗效观察[J]. 中国医药导报, 2010(23): 48-49. |
| [6] | 郭沂涟, 李义召, 孙琳, 等. 甲基强的松龙冲击疗法治疗神经免疫性疾病的研究[J]. 临床神经病学杂志, 2000, 13(1): 55-56. |
| [7] | Thompson, A.J., Kennard, C., Swash, M., et al. (1989) Relative Efficacy of Intravenous Methylprednisolone and ACTH in the Treatment of Acute Relapse in MS. Neurology, 39, 969-971. https://doi.org/10.1212/WNL.39.7.969 |
| [8] | 李昭晖. 甲基强的松龙早期短程冲击疗法与地塞米松治疗小儿重症病毒性脑炎的临床对照研究[J]. 中国保健营养, 2019, 29(1): 83-85. |
| [9] | 汪明辉. 甲基强的松龙冲击治疗小儿神经免疫性疾病临床分析[J]. 中外医疗, 2012, 31(27): 108-109. |
| [10] | 郭沂涟, 李义召, 孙琳, 等. 甲基强的松龙冲击疗法治疗神经免疫性疾病的研究[J]. 临床神经病学杂志, 2000, 13(1): 55-56. |
